凯撒旅业：接受广发证券等投资者调研

Group 1 - Caesar Travel Industry announced that on November 27, 2025, it will accept investor research from Guangfa Securities and others, with the participation of Deputy General Manager Xing Zhihuang and others to answer investor questions [1] Group 2 - The innovative drug industry is facing challenges, with a significant price increase of 30% over two months, and the cost of a single experimental monkey reaching 120,000 yuan, leading to a situation where there is "price but no monkeys" available, with an annual domestic shortfall of approximately 10,000 monkeys [1]